Abstract
To investigate the in vitro activity of the fourth generation cephalosporin FK-037, MICs were determined for 80 strains of methicillin-resistantStaphylococcus aureus from 11 countries. Methicillin and cefamandole served as comparators. The method ensured good expression of PBP2′ by use of a large inoculum, salt supplement and incubation for 48 hours at 30°C. FK-037 was twice as active as cefamandole against both strains with high-level and strains with low-level methicillin resistance (geometric mean MICs 23.4 and 10.8 mg/l, respectively).
Similar content being viewed by others
References
Mine Y, Watanabe Y, Sakamoto H, Hatano K, Kuno K, Kamimura T, Tawara S, Matsumoto Y, Matsumoto F, Kuwahara S Excellent activity of FK-037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci. Journal of Antibiotics 1993, 46: 99–119.
Fu KP, Foleno BD, Lafredo SC, LoCoco JM, Isaacson DM In vitro and in vivo antibacterial properties of FK-037, a novel parenteral broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy 1993, 37: 301–307.
Neu HC, Chin NX, Huang HB In vitro activity and β-lactamase stability of FK-037, a parenteral cephalosporin. Antimicrobial Agents and Chemotherapy 1993, 37: 566–573.
Washington JA, Jones RN, Gerlach EH, Murray PR, Allen SD, Knapp CC Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftaxidime, and cefuroxime. Antimicrobial Agents and Chemotherapy 1993, 37: 1696–1700.
National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing. Document M100-S4. NCCLS, Villanova, PA, 1992.
Yawata M Control of MRSA infections. Lancet 1993, 341: 483.
Milne LM, Crow MR, Emptage AGM, Selkon JB Effects of culture media on detection of methicillin resistance inStaphylococcus aureus and coagulase-negative staphylococci by disc diffusion methods. Journal of Clinical Pathology 1993, 46: 394–397.
Hamilton-Miller JMT, Maple PAC Antibiogram typing of methicillin-resistantStaphylococcus aureus: a comparison with phage typing, biotyping and API Staph. Zentrallblatt für Bakteriologie 1993, 279: 214–224.
Brumfitt W, Hamilton-Miller JMT Methicillin-resistantStaphylococcus aureus. New England Journal of Medicine 1989, 320: 1188–1196.
Ling JM, Lam AW, Cheng AF, French GL Activity of β-lactam antibiotics in an animal model against methicillin-resistantStaphylococcus aureus. Journal of Antimicrobial Chemotherapy 1993, 32: 919–920.
Toyosawa T, Miyazaka S, Tsuji A, Yamaguchi K, Goto S In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin. Antimicrobial Agents and Chemotherapy 1993, 37: 60–66.
Tanaka M, Otsuki M, Nishino T In vitro and in vivo activities of DQ-2556 and its mode of action. Antimicrobial Agents and Chemotherapy 1992, 36: 2595–2601.
Iwahi T, Okonogi K, Yamazaki T, Shiki S, Kondo M, Miyake A, Imada A In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicrobial Agents and Chemotherapy 1992, 36: 1358–1366.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hamilton-Miller, J.M.T. Activity of the fourth generation cephalosporin FK-037 against methicillin-resistantStaphylococcus aureus under conditions maximizing PBP2′ production. Eur. J. Clin. Microbiol. Infect. Dis. 13, 1053–1055 (1994). https://doi.org/10.1007/BF02111826
Issue Date:
DOI: https://doi.org/10.1007/BF02111826